FindMyKOL
Clinical trialNCT01956474TerminatedPhase 2Interventional

CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas

SponsorCxlusaEnrollment1,324Keratoconus
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the efficacy of ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) as a method to increase the biomechanical and biochemical stability of the cornea by inducing additional cross-links within or between collagen fibers using UVA light and the photo- mediator riboflavin.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Center for Excellence in Eye Care

    Miami, Florida, United States

  • Stulting Research Center at Woolfson Eye Institute

    Atlanta, Georgia, United States

  • Tlc Laser Eye Center

    Rockville, Maryland, United States

  • Talamo Hatch Laser Eye Consultants, Llc

    Boston, Massachusetts, United States

  • Cleveland Eye Clinic

    Brecksville, Ohio, United States

  • Tlc Laser Eye Center

    Fairfax, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2013
Primary completion
3 Feb 2017
Completion
3 Feb 2017
Last update posted
12 Oct 2018
Registered enrollment
1,324
Registry id
NCT01956474

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.